What does Apotheek de Merode do?

Apotheek de Merode is a pharmacy in Mechelen. Private Limited, started on 29 May 2012, 1 establishment.

What is the address of Apotheek de Merode?

The registered office of Apotheek de Merode is located at Frederik de Merodestraat 60, 2800 Mechelen.

Is Apotheek de Merode still active?

Yes. According to the CBE (31 October 2026) Apotheek de Merode is active, legal situation “Normale toestand”, started on 29 May 2012.

Is Apotheek de Merode registered on Peppol?

Yes, Apotheek de Merode is registered on the Peppol network with ID 0208:0846479309.

What is the enterprise number of Apotheek de Merode?

The enterprise number of Apotheek de Merode is BE0846479309.

When was Apotheek de Merode founded?

Apotheek de Merode was founded on 29 May 2012.

Who are the directors of Apotheek de Merode?

According to the 2025 annual accounts, the directors of Apotheek de Merode are: Wim Van Raemdonck, Vrb Farma.

Is Apotheek de Merode a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 May 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek de Merode make in 2025?

Apotheek de Merode posted a profit after taxes of € 47,461 in financial year 2025.

What is the revenue of Apotheek de Merode?

As a small company, Apotheek de Merode is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 124,252.

How many employees does Apotheek de Merode have?

According to the 2025 annual accounts, Apotheek de Merode has 0.7 full-time equivalents (FTE).

Apotheek de Merode (Private Limited) - Mechelen

Dossier Apotheek de Merode, printed on 1 November 2026 from databakkes.be/en/0846479309/apotheek-de-merode. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek de Merode from Mechelen, company number BE0846479309, closed financial year 2025 with a result of € 47,461 after tax. For that financial year Apotheek de Merode recorded a gross margin of € 124,252 and equity of € 319,357. Compared with financial year 2024, the result moved from € 37,844 to € 47,461. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 319,357

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 47,461

▲ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 74,287

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

42 % of the profit went to the shareholders, mostly to VRB FARMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 20,863

▲ 6% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,958

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 256,717

▼ 8% vs 2024

€ 23,621 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 49,919

▼ 49% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 1,889

▲ 100% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 119,066 Gross margin 2022: € 119,066 First fiscal year in the series	€ 100,339 Gross margin 2023: € 100,339 ▼ 16% vs 2022 (€ 119,066) Unfavourable step	€ 81,095 Gross margin 2024: € 81,095 ▼ 19% vs 2023 (€ 100,339) Unfavourable step	€ 124,252 Gross margin 2025: € 124,252 ▲ 53% vs 2024 (€ 81,095) Favourable step	▲ 53%
Profit after taxes	€ 71,563 Profit after taxes 2022: € 71,563 First fiscal year in the series	€ 49,114 Profit after taxes 2023: € 49,114 ▼ 31% vs 2022 (€ 71,563) Unfavourable step	€ 37,844 Profit after taxes 2024: € 37,844 ▼ 23% vs 2023 (€ 49,114) Unfavourable step	€ 47,461 Profit after taxes 2025: € 47,461 ▲ 25% vs 2024 (€ 37,844) Favourable step	▲ 25%
Equity	€ 259,938 Equity 2022: € 259,938 First fiscal year in the series	€ 264,051 Equity 2023: € 264,051 ▲ 2% vs 2022 (€ 259,938) Favourable step	€ 291,895 Equity 2024: € 291,895 ▲ 11% vs 2023 (€ 264,051) Favourable step	€ 319,357 Equity 2025: € 319,357 ▲ 9% vs 2024 (€ 291,895) Favourable step	▲ 9%
Total debts	€ 105,749 Total debts 2022: € 105,749 First fiscal year in the series	€ 191,280 Total debts 2023: € 191,280 ▲ 81% vs 2022 (€ 105,749) Unfavourable step	€ 387,310 Total debts 2024: € 387,310 ▲ 102% vs 2023 (€ 191,280) Unfavourable step	€ 328,969 Total debts 2025: € 328,969 ▼ 15% vs 2024 (€ 387,310) Favourable step	▼ 15%
Cash	€ 101,988 Cash 2022: € 101,988 First fiscal year in the series	€ 127,255 Cash 2023: € 127,255 ▲ 25% vs 2022 (€ 101,988) Favourable step	€ 94,745 Cash 2024: € 94,745 ▼ 26% vs 2023 (€ 127,255) Unfavourable step	€ 74,287 Cash 2025: € 74,287 ▼ 22% vs 2024 (€ 94,745) Unfavourable step	▼ 22%
Retained profit	€ 120,736 Retained profit 2022: € 120,736 First fiscal year in the series	€ 124,850 Retained profit 2023: € 124,850 ▲ 3% vs 2022 (€ 120,736) Favourable step	€ 152,694 Retained profit 2024: € 152,694 ▲ 22% vs 2023 (€ 124,850) Favourable step	€ 180,155 Retained profit 2025: € 180,155 ▲ 18% vs 2024 (€ 152,694) Favourable step	▲ 18%
Dividend	€ 61,000 Dividend 2022: € 61,000 First fiscal year in the series	€ 45,000 Dividend 2023: € 45,000 ▼ 26% vs 2022 (€ 61,000) Unchanged	€ 10,000 Dividend 2024: € 10,000 ▼ 78% vs 2023 (€ 45,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 ▲ 100% vs 2024 (€ 10,000) Unchanged	▲ 100%
Bank debt	€ 7,303 Bank debt 2022: € 7,303 First fiscal year in the series	€ 8,513 Bank debt 2023: € 8,513 ▲ 17% vs 2022 (€ 7,303) Unfavourable step	€ 277,633 Bank debt 2024: € 277,633 ▲ € 269,121 vs 2023 (€ 8,513) Unfavourable step	€ 256,717 Bank debt 2025: € 256,717 ▼ 8% vs 2024 (€ 277,633) Favourable step	▼ 8%
Balance sheet total	€ 365,686 Balance sheet total 2022: € 365,686 First fiscal year in the series	€ 455,331 Balance sheet total 2023: € 455,331 ▲ 25% vs 2022 (€ 365,686) Unchanged	€ 679,206 Balance sheet total 2024: € 679,206 ▲ 49% vs 2023 (€ 455,331) Unchanged	€ 648,325 Balance sheet total 2025: € 648,325 ▼ 5% vs 2024 (€ 679,206) Unchanged	▼ 5%
Employees (FTE)	-	0.7 Employees (FTE) 2023: 0.7 First fiscal year in the series	0.7 Employees (FTE) 2024: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2025: 0.7 Unchanged (0.7) Unchanged

Key figures of Apotheek de Merode, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek de Merode?

What happened at Apotheek de Merode in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 47,461 (▲ 25% vs 2024). Source: NBB ↗
2015 Wim Van Raemdonck became a director. NBB
2015 Vrb Farma became a director. NBB
May 29, 2012 New establishment in Mechelen. KBO
May 29, 2012 Start of the company according to the CBE. KBO

In short

From € 71,563 profit in 2022 to € 47,461 profit in 2025.

Paid € 60,639 in corporate taxes since 2022.

Best year ever: 2022, with € 71,563 profit.

Paid out € 136,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

VRB FARMA 100%

The stake of VRB FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek de Merode

Behind Apotheek de Merode are Wim Van Raemdonck and Vrb Farma. The shares are held by VRB FARMA (100%).

Directors

According to the 2025 annual accounts

Wim Van Raemdonck

Director

Also active at: VRB FARMA

since 2015

Vrb Farma

Director · represented by Shana Biesmans

since 2015

Shareholders

VRB FARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Frederik de Merodestraat 60

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VRB FARMA same network

€ 46,476 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0846.479.309

VAT number

BE 0846.479.309

Registered office

Frederik de Merodestraat 60, 2800 Mechelen

Names & denominations

Apotheek de Merode

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 May 2012

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in corrigerende brillen, lenzen en zonnebrillen

Detailhandel in fotografische en optische artikelen en in precisieinstrumenten in gespecialiseerde winkels

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek de Merode

Financials

What happened to Apotheek de Merode?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions